Gregory Hamilton
Epigenomics has appointed Gregory Hamilton as CEO. Hamilton will succeed Thomas Taapken who plans to leave the company. Prior to joining Epigenomics, Hamilton held executive positions in a number of diagnostics companies, including CEO and director of AltheaDx, chief operating officer and CFO of Enigma Diagnostics, vice president of operations and finance at Third Wave Technologies, and vice president of operations at Hologic.